blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3394091

EP3394091 - CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  22.01.2021
Database last updated on 19.10.2024
FormerRequest for examination was made
Status updated on  28.09.2018
FormerThe international publication has been made
Status updated on  16.06.2017
Most recent event   Tooltip12.12.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Merck Sharp & Dohme LLC
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
[2022/42]
Former [2018/44]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Inventor(s)01 / PALANI, Anandan
2000 Galloping Hill Road
Kenilworth New Jersey 07033 / US
02 / CARRINGTON, Paul, E.
2000 Galloping Hill Road
Kenilworth New Jersey 07033 / US
03 / PESSI, Antonello
Viale Citta
D'Europa 679
00144 Rome / IT
04 / LAHM, Armin
Viale Citta
D'Europa 679
00144 Rome / IT
05 / BIANCHI, Elisabetta
Via Pontina KM 30
600 Pomezia
00040 Rome / IT
06 / DEMARTIS, Anna
Via Pontina KM 30
600 Pomezia
00040 Rome / IT
 [2018/44]
Representative(s)Merck Sharp & Dohme LLC
120 Moorgate
London EC2M 6UR / GB
[N/P]
Former [2018/44]Hussain, Deeba
Merck Sharp & Dohme Limited
Hertford Road
Hoddesdon
Hertfordshire EN11 9BU / GB
Application number, filing date16873641.105.12.2016
[2018/44]
WO2016US64882
Priority number, dateUS201562264928P09.12.2015         Original published format: US 201562264928 P
[2018/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2017100107
Date:15.06.2017
Language:EN
[2017/24]
Type: A2 Application without search report 
No.:EP3394091
Date:31.10.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 15.06.2017 takes the place of the publication of the European patent application.
[2018/44]
Search report(s)International search report - published on:US17.08.2017
(Supplementary) European search report - dispatched on:EP19.11.2019
ClassificationIPC:C07K14/575, A61K38/16, A61P1/16, A61P3/10, A61K38/00
[2019/25]
CPC:
A61K38/16 (EP,US); A61P1/16 (EP,US); A61P3/10 (EP,US);
C07K14/575 (EP,US); A61K38/00 (EP,US)
Former IPC [2018/44]C07K14/605, C07K14/575, C07K14/435
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/44]
TitleGerman:CO-AGONISTEN VON GLUCAGON- UND GLP-1-REZEPTOREN[2018/44]
English:CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS[2018/44]
French:CO-AGONISTES DES RÉCEPTEURS DE GLUCAGON ET DE GLP-1[2018/44]
Entry into regional phase09.07.2018National basic fee paid 
09.07.2018Search fee paid 
09.07.2018Designation fee(s) paid 
09.07.2018Examination fee paid 
Examination procedure29.06.2018Date on which the examining division has become responsible
09.07.2018Examination requested  [2018/44]
18.09.2020Amendment by applicant (claims and/or description)
22.01.2021Despatch of a communication from the examining division (Time limit: M06)
24.08.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
02.11.2021Reply to a communication from the examining division
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
02.11.2021Request for further processing filed
02.11.2021Full payment received (date of receipt of payment)
Request granted
11.11.2021Decision despatched
The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
18.09.2020Request for further processing filed
18.09.2020Full payment received (date of receipt of payment)
Request granted
29.09.2020Decision despatched
The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
18.09.2020Request for further processing filed
18.09.2020Full payment received (date of receipt of payment)
Request granted
29.09.2020Decision despatched
Fees paidRenewal fee
10.12.2018Renewal fee patent year 03
10.12.2019Renewal fee patent year 04
09.12.2020Renewal fee patent year 05
16.12.2021Renewal fee patent year 06
09.12.2022Renewal fee patent year 07
12.12.2023Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO2010148089  (UNIV INDIANA RES & TECH CORP [US], et al) [X] 1-4,6-14,16,17 * page 42, lines 5-6 * * page 43, lines 27,28 * * page 58, line 30 - page 59, line 12 * * page 95, line 25 - page 96, line 2 * * examples 32,34 * * claims 1,8,16, * * sequences 582,584 * [Y] 15;
 [Y]  - KALRA S, "Newer basal insulin analogues: Degludec, Detemir, Glargine", PAKISTAN MEDICAL ASSOCIATION. JOURNAL, PAKISTAN MEDICAL ASSOCIATION, KARACHI, PK, (20131101), vol. 63, no. 11, ISSN 0030-9982, pages 1442 - 1444, XP009193859 [Y] 15 * abstract * * page 1443, column r, paragraphs 2-4 *
International search[A]US2015307580  (CARRINGTON PAUL E [US], et al) [A] 1-4 * ; paragraphs [0012], [0054]-[0056], [0058], [0063], [0091], [0140] *;
 [A]US8703701  (DIMARCHI RICHARD D [US]) [A] 1-4 * ; column 2, lines 43-44; column 4, lines 50-52; column 5, lines 50-52; column 29, lines 7-11; column 33, lines 36-39; column 34, lines 37-40; column 40, lines 22-25; column 69, lines 38-42 *;
 [A]US2011190200  (DIMARCHI RICHARD D [IN], et al) [A] 1-4 * ; paragraphs [0018], [0021], [0118], [0121], [0161], [0291], [0293]; SEQ ID NO: 77 *;
 [A]WO2011143208  (UNIV INDIANA RES & TECH CORP [US], et al) [A] 1-4 * ; paragraphs [0011], [00116], [00118], [00373], [00401], [00404]; SEQ ID NO: 877 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.